Loading...
XJPX
7730
Market cap920mUSD
Oct 09, Last price  
1,492.00JPY
1D
1.15%
1Q
-11.98%
Jan 2017
60.60%
IPO
296.69%
Name

Mani Inc

Chart & performance

D1W1MN
XJPX:7730 chart
P/E
31.65
P/S
4.90
EPS
47.14
Div yield, %
2.64%
Shrs. gr., 5y
0.02%
Rev. gr., 5y
14.54%
Revenues
29.97b
+5.10%
7,622,197,0008,162,520,0008,790,517,0009,291,986,0009,443,774,0009,460,015,0009,693,819,0009,342,337,00011,440,135,00013,833,155,00016,555,075,00017,167,554,00020,102,760,00018,327,297,00015,200,176,00017,190,000,00020,416,000,00024,488,000,00028,513,000,00029,968,000,000
Net income
4.64b
-26.14%
1,847,528,0002,101,084,0002,160,788,0002,156,305,0002,246,365,0002,021,116,0002,179,168,0002,180,287,0002,606,507,0002,932,876,0003,005,645,0003,315,268,0003,770,877,0006,101,796,0003,329,000,0004,291,000,0005,290,000,0005,953,000,0006,286,000,0004,643,000,000
CFO
7.03b
-10.10%
2,191,000,0002,207,000,0002,576,000,0002,812,139,0002,861,627,0002,060,161,9992,895,436,0002,077,366,0003,472,899,0002,993,390,0003,599,556,0004,830,387,0005,608,773,0005,331,135,0001,997,766,0006,413,000,0006,572,000,0008,032,000,0007,820,000,0007,030,000,000
Dividend
Aug 28, 202624 JPY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Mani, Inc. engages in the manufacture and supply of surgical and dental instruments in Japan, Asia, Europe, North America, and internationally. The company operates through three segments: Surgical Products, Eyeless Needle Products, and Dental Products. The company offers surgical instruments, such as maniplers, vessel knives, ENT knives, and stainless wire needles; and ophthalmic instruments, including ophthalmic sutures and knives, and trocar kits for vitrectomy. It also provides surgical eyeless, eyed, taper point, cutting, ophthalmic needles; and dental instruments, such as endodontic instruments, endodontic rotary instruments, root canal obturation, diamond and carbide burs, finishing and polishing instruments, sutures and surgical needles, endodontic micro-accessories, and endodontic accessories. Mani, Inc. was founded in 1956 and is headquartered in Utsunomiya, Japan.

Key people

Masahiko Saito
Executive Chairman, Chief Director of Quality Assurance · since 2025
Masaya Watanabe
Executive President, Chief Executive Officer, Representative Executive Officer, Director · since 2025
Kazuo Takahashi
Executive Vice President,Chief Financial Officer,Chief Risk Officer, Manager of Business Planning Office, Director · since 2025
Takayuki Yamamoto
Chief Financial Officer, Chief Risk Officer, Managing Executive Officer, Manager of Business Planning · since 2025
Hideshi Fukumoto
Global Chief Technology Officer, Senior Managing Executive Officer, Manager of Monozukuri · since 2025
Shuichi Kurita
Senior Managing Executive Officer, Manager of Business, Chief Director of Global Sales · since 2025
Tomomi Kosaka
Managing Executive Officer, Assistant Manager of Monozukuri, Chief Director of Production, Chairman of Subsidiaries · since 2024
Kentaro Inatomi
Administrative Officer, President of Subsidiary · since 2025
Noritomo Koike
Executive Officer, Chief Director of Product Business · since 2025
Kaoru Ogane
Administrative Officer, Chief Director of Global Operations · since 2025
Norio Ozaki
Executive Officer, Chief Director of Development · since 2025
Hajime Terada
Executive Officer, Chief Director of Human Resources and General Affairs · since 2025
Toshihide Takai
Director · since 2025
Yukio Matsui
Independent Director · since 2024
Chairman of the Board of Directors, Independent Director · since 2024
Yukiko Moriyama
Independent Director · since 2020
Hiroyuki Sasa
Independent Director · since 2025
Tatsushi Yano
Independent Director · since 2021
IPO date
Jun 29, 2001
Employees
3,417
Domiciled in
JP
Incorporated in
JP

Valuation

Title
JPY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2025‑082024‑082023‑082022‑082021‑082020‑082019‑082018‑082017‑08
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT